Literature DB >> 12934772

Left ventricular intracavitary mass and pericarditis secondary to metastatic renal cell carcinoma--a case report.

Arshad M Safi1, Maurice Rachko, Sharon Sadeghinia, Amadeldin Zineldin, Jinwen Dong, Richard A Stein.   

Abstract

Cardiac metastases from renal cell carcinoma are a well-recognized entity. However, this phenomenon is extremely rare in the absence of vena caval extension. The authors report a patient who after successful resection of renal cell carcinoma presented with left ventricular mass causing left ventricular outflow tract obstruction. There was also metastatic pericardial and intramyocardial involvement. Such a unique combination of cardiac metastasis, in the same patient, has not been reported previously.

Entities:  

Mesh:

Year:  2003        PMID: 12934772     DOI: 10.1177/000331970305400416

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  4 in total

1.  Occult infiltrating bi-ventricular papillary renal cell carcinoma metastasis found during coronary artery bypass graft surgery.

Authors:  Nathan M Mollberg; Nicholas B Johnson; Shan-Chinga Ying; Khaled Abdelhady; Malek G Massad; Doreen E Chung
Journal:  Can Urol Assoc J       Date:  2012-04       Impact factor: 1.862

Review 2.  Cardiac metastasis from renal cell carcinoma without inferior vena involvement: a review of the literature based on a case report. Two different patterns of spread?

Authors:  Fable Zustovich; Fedra Gottardo; Luca De Zorzi; Attilio Cecchetto; Massimo Dal Bianco; Endai Mauro; Giuseppe Cartei
Journal:  Int J Clin Oncol       Date:  2008-06-14       Impact factor: 3.402

3.  Cardiac Metastasis in Renal Cell Carcinoma without Vena Cava or Atrial Involvement: an Unusual Presentation of Metastatic Disease.

Authors:  Ben Zhang; Joseph Malouf; Phillip Young; Manish Kohli; Roxana Dronca
Journal:  Rare Tumors       Date:  2013-07-05

4.  Renal cell carcinoma with intramyocardial metastases.

Authors:  Anna M Czarnecka; Pawel Sobczuk; Fei Lian; Cezary Szczylik
Journal:  BMC Urol       Date:  2014-09-06       Impact factor: 2.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.